Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension-Reference-Cited by-同舟云学术

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension

Published:2015-11 Issue:5 Volume:66 Page:457-467
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Iglarz Marc,Landskroner Kyle,Bauer Yasmina,Vercauteren Magali,Rey Markus,Renault Berengère,Studer Rolf,Vezzali Enrico,Freti Diego,Hadana Hakim,Schläpfer Manuela,Cattaneo Christophe,Bortolamiol Céline,Weber Edgar,Whitby Brian R.,Delahaye Stéphane,Wanner Daniel,Steiner Pauline,Nayler Oliver,Hess Patrick,Clozel Martine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference36 articles.

1. At the heart of tissue: endothelin system and end-organ damage.;Iglarz;Clin Sci (Lond),2010

2. . Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries.;Dagassan;J Cardiovasc Pharmacol,1996

3. . Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension.;Bauer;Circulation,2002

4. . Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences.;Desmarets;Biochemistry,1996

5. Why are circulating concentrations of endothelin-1 so low Cardiovasc Res.;Frelin,1994

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive review of potential drugs with anti-pulmonary fibrosis properties;Biomedicine & Pharmacotherapy;2024-04

2. Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib;Respiratory Medicine Case Reports;2024

3. A Bioinformatic Algorithm based on Pulmonary Endoarterial Biopsy for Targeted Pulmonary Arterial Hypertension Therapy;The Open Respiratory Medicine Journal;2023-10-04

4. Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center;Pediatric Drugs;2023-06-03

5. Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis;American Journal of Respiratory Cell and Molecular Biology;2023-03